JMP Securities Reiterates Market Outperform on Precigen, Maintains $14 Price Target
Portfolio Pulse from Benzinga Newsdesk
JMP Securities analyst Jason Butler reiterated a Market Outperform rating on Precigen (NASDAQ:PGEN) and maintained a $14 price target.
June 05, 2023 | 12:09 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
JMP Securities analyst Jason Butler reiterated a Market Outperform rating on Precigen and maintained a $14 price target.
The reiteration of the Market Outperform rating and maintenance of the $14 price target by JMP Securities analyst Jason Butler indicates a positive outlook for Precigen's stock. This news is likely to have a positive impact on the stock price in the short term as it reaffirms the analyst's confidence in the company's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100